Dose-Ranging Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine

NCT06077656 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

220

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumococcal Vaccines

Interventions

BIOLOGICAL: IVT PCV-25 Formulation A
BIOLOGICAL: IVT PCV-25 Formulation B
BIOLOGICAL: IVT PCV-25 Formulation C
BIOLOGICAL: PCV 20

Sponsor

Inventprise Inc.

Collaborators

[object Object]
[object Object]
[object Object]